The Oncology Institute, Inc. TOI Change in Other Liabilities
Change in Other Liabilities at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s change in other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s change in other liabilities?
- The Oncology Institute, Inc. (TOI) reported change in other liabilities of $0 in Q1 2026.
- How has The Oncology Institute, Inc.'s change in other liabilities changed year-over-year?
- The Oncology Institute, Inc.'s change in other liabilities decreased by 100.0% year-over-year, from $1K to $0.
- What is the long-term trend for The Oncology Institute, Inc.'s change in other liabilities?
- Over 3 years (2021 to 2024), The Oncology Institute, Inc.'s change in other liabilities has grown at a -36.8% compound annual growth rate (CAGR), from $809K to -$204K.
- What does change in other liabilities mean?
- Change in miscellaneous liabilities affecting operating cash flow.